Literature DB >> 28979500

The role of electroencephalography in the diagnosis of serotonin syndrome.

Theeba Krishnamoorthy1, John Knighton1, Louis Merton1.   

Abstract

Serotonin syndrome is a potentially life-threatening side-effect of agents that enhance synaptic serotonin levels. With the increasing use of serotoninergic agents greater awareness of serotonin syndrome is necessary, including the potential for drug interactions with serotoninergic agents to produce serotonin syndrome. Clinical presentation ranges from mild reactions to a severe toxic state involving generalized tonic-clonic seizures, fevers exceeding 40℃ or coma. This case highlights the necessity of considering serotonin syndrome alongside other differential diagnoses: neuroleptic malignant syndrome, infectious cause, atypical seizures and delirium tremens, in the setting of altered mental state with abnormal neurology. It highlights the potential diagnostic use of electroencephalography in supporting a diagnosis of serotonin syndrome.

Entities:  

Keywords:  Serotonin syndrome; adverse drug reaction; intensive care; quetiapine; venlafaxine

Year:  2016        PMID: 28979500      PMCID: PMC5606516          DOI: 10.1177/1751143715626732

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  14 in total

Review 1.  Serotonin syndrome: a brief review.

Authors:  Philippe Birmes; Dominique Coppin; Laurent Schmitt; Dominique Lauque
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

2.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

3.  Neuroleptic malignant syndrome associated with quetiapine and venlafaxine use: a case report and discussion.

Authors:  Gary Woods; Catherine Taggart; Robert Boggs; Ian Cadden
Journal:  Ther Adv Psychopharmacol       Date:  2013-02

4.  Linezolid and serotonin syndrome.

Authors:  Davin K Quinn; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

5.  Triphasic waves in serotonin syndrome.

Authors:  G L Dike
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

6.  Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions.

Authors:  Ewa Greenier; Valentina Lukyanova; Lynn Reede
Journal:  AANA J       Date:  2014-10

7.  2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report.

Authors:  James B Mowry; Daniel A Spyker; Louis R Cantilena; J Elise Bailey; Marsha Ford
Journal:  Clin Toxicol (Phila)       Date:  2013-12       Impact factor: 4.467

8.  2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report.

Authors:  James B Mowry; Daniel A Spyker; Louis R Cantilena; Naya McMillan; Marsha Ford
Journal:  Clin Toxicol (Phila)       Date:  2014-12       Impact factor: 4.467

9.  Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.

Authors:  N K Perry
Journal:  Postgrad Med J       Date:  2000-04       Impact factor: 2.401

10.  5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome.

Authors:  Patrick Osei-Owusu; Amy James; James Crane; Karie E Scrogin
Journal:  J Pharmacol Exp Ther       Date:  2005-03-02       Impact factor: 4.030

View more
  1 in total

1.  Focal seizure as a manifestation of serotonin syndrome: case report.

Authors:  Eyad Almallouhi; Mohamad Rahwan; Helen Dainton; Leonardo Bonilha
Journal:  Avicenna J Med       Date:  2019 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.